Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FT999
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,075
Award facts
- Contract value 100% obligated
- $12,074.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $12,074.99. This is a firm fixed price, non-set-aside competitive delivery order with an ultimate completion date of November 19, 2025, and performance at the vendor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill open competition procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This delivery order for RINVOQ ER—a JAK inhibitor used in treating rheumatoid arthritis and other inflammatory conditions—reflects the company's ongoing role in supporting Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to meet military medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FT999?
SPE2DR26FT999 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FT999 worth?
The government has obligated $12,075 on SPE2DR26FT999.
Is contract SPE2DR26FT999 an order under another contract?
Yes. SPE2DR26FT999 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT999 competed?
The extent of competition for SPE2DR26FT999 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award